Are you a new member? Sign up now
Login area
| Sign up
close
SUPRAX - 200mg - 6
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD08 | B | Cefixime (trihydrate) - 200mg | 1122 | 26992 | SUPRAX | 200mg | 6 | Capsule | Oral | Droguerie de l'Union | Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan | Jordan | 1,067,011 L.L | 23.08 | A2 | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DD08 | B | Cefixime (trihydrate) - 200mg | 8877 | 104316/1 | SUPRAX | 200mg | 6 | Capsule | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries under licence of Astellas Pharma Inc Japan | Saudi Arabia | 1,067,011 L.L | 23.08 | A2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| J01DD08 | G | Cefixime (trihydrate) - 200mg | 7837 | 59414/1 | FIXIM | 200mg | 14 | Capsule | Oral | Droguerie Phenicia | Normon SA | Spain | 890,968 L.L | 23.08 | A2 | Normon SA | Spain | 2/5/2024 | 0 |
| J01DD08 | G | Cefixime - 200mg | 9039 | 108416/1 | MUREX 200 | 200mg | 8 | Capsule | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 430,030 L.L | 23.08 | A1 | Dar Al Dawa Development & Investment Co Ltd | Jordan | 2/5/2024 | 0 |
| J01DD08 | G | Cefixime (trihydrate) - 200mg | 5697 | 23647/06 | WINEX | 200mg | 8 | Capsule | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 731,050 L.L | 23.08 | A2 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024